Get started
SANTEN PHARMACEUTICAL COSANTEN PHARMACEUTICAL COSANTEN PHARMACEUTICAL CO

SANTEN PHARMACEUTICAL CO

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

4536 chart


Full chart

4536 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪647.75 B‬ JPY
Dividend yield (indicated)
1.91%
Price to earnings Ratio (TTM)
24.0
Basic EPS (TTM)
75.0 JPY
Net income (FY)
‪26.64 B‬ JPY
Revenue (FY)
‪301.96 B‬ JPY
Shares float
‪307.29 M‬
Beta (1Y)
0.35

Employees


Employees (FY)
‪3.74 K‬
Change (1Y)
−400 −9.65%
Revenue / Employee (1Y)
‪532.87 K‬ JPY
Net income / Employee (1Y)
‪47.00 K‬ JPY

About SANTEN PHARMACEUTICAL CO


Sector
Health Technology
CEO
Takeshi Ito
Headquarters
Osaka
Website
santen.co.jp
Founded
2016
ISIN
JP3336000009
FIGI
BBG000BJYVK7
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

4536 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4536 is 1,766.0 JPY — it has decreased by −0.87% in the past 24 hours. Watch SANTEN PHARMACEUTICAL CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange SANTEN PHARMACEUTICAL CO stocks are traded under the ticker 4536.
4536 stock has fallen by −0.90% compared to the previous week, the month change is a −1.15% fall, over the last year SANTEN PHARMACEUTICAL CO has showed a 29.95% increase.
We've gathered analysts' opinions on SANTEN PHARMACEUTICAL CO future price: according to them, 4536 price has a max estimate of 2,500.00 JPY and a min estimate of 1,550.00 JPY. Watch 4536 chart and read a more detailed SANTEN PHARMACEUTICAL CO stock forecast: see what analysts think of SANTEN PHARMACEUTICAL CO and suggest that you do with its stocks.
4536 reached its all-time high on Jan 16, 2020 with the price of 2,234.0 JPY, and its all-time low was 200.0 JPY and was reached on Oct 9, 2002. View more price dynamics on 4536 chart.
See other stocks reaching their highest and lowest prices.
4536 stock is 2.46% volatile and has beta coefficient of 0.35. Track SANTEN PHARMACEUTICAL CO stock price on the chart and check out the list of the most volatile stocks — is SANTEN PHARMACEUTICAL CO there?
Today SANTEN PHARMACEUTICAL CO has the market capitalization of ‪633.64 B‬, it has increased by 1.65% over the last week.
Yes, you can track SANTEN PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
SANTEN PHARMACEUTICAL CO is going to release the next earnings report on Nov 7, 2024. Keep track of upcoming events with our Earnings Calendar.
4536 earnings for the last quarter are 29.59 JPY per share, whereas the estimation was 25.99 JPY resulting in a 13.86% surprise. The estimated earnings for the next quarter are 21.69 JPY per share. See more details about SANTEN PHARMACEUTICAL CO earnings.
SANTEN PHARMACEUTICAL CO revenue for the last quarter amounts to ‪74.77 B‬ JPY, despite the estimated figure of ‪75.24 B‬ JPY. In the next quarter, revenue is expected to reach ‪74.62 B‬ JPY.
4536 net income for the last quarter is ‪10.63 B‬ JPY, while the quarter before that showed ‪30.00 M‬ JPY of net income which accounts for ‪35.34 K‬% change. Track more SANTEN PHARMACEUTICAL CO financial stats to get the full picture.
As of Nov 5, 2024, the company has ‪3.74 K‬ employees. See our rating of the largest employees — is SANTEN PHARMACEUTICAL CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANTEN PHARMACEUTICAL CO EBITDA is ‪71.93 B‬ JPY, and current EBITDA margin is 23.21%. See more stats in SANTEN PHARMACEUTICAL CO financial statements.
Like other stocks, 4536 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANTEN PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SANTEN PHARMACEUTICAL CO technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SANTEN PHARMACEUTICAL CO stock shows the buy signal. See more of SANTEN PHARMACEUTICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.